Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

NCT00506129 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Disorder Related to Bone Marrow Transplantation

Interventions

DRUG: Fludarabine
DRUG: Melphalan
PROCEDURE: Allogeneic Transplant
DRUG: Thymoglobulin

Sponsor

M.D. Anderson Cancer Center